Understanding the Role of 4,5,6,7-Tetrahydro-5-Methyl-Thiazolo[5,4-c]Pyridine-2-Carboxylic Acid Hydrochloride in Pharmaceutical Synthesis
A crucial intermediate for developing advanced cardiovascular and antithrombotic therapies.
Get a Quote & SampleProduct Core Value
![4,5,6,7-Tetrahydro-5-Methyl-Thiazolo[5,4-c]Pyridine-2-Carboxylic Acid Hydrochloride](https://www.nbinno.com/webimg/gemini_68890d2513c8d_1753812261.png)
4,5,6,7-Tetrahydro-5-Methyl-Thiazolo[5,4-c]Pyridine-2-Carboxylic Acid Hydrochloride
This compound serves as a vital building block in the synthesis of sophisticated pharmaceutical compounds, most notably Edoxaban. Its precise chemical structure and high purity are essential for ensuring the efficacy and safety of downstream drug products, playing a critical role in the development of modern antithrombotic treatments.
- The synthesis of antithrombotic agents relies heavily on high purity pharmaceutical intermediates like this compound, ensuring the final drug's effectiveness.
- This product is instrumental in the development of FXa inhibitors, a critical class of drugs for preventing and treating blood clots.
- As a key Edoxaban intermediate, it is crucial for manufacturers aiming to produce this important cardiovascular medication.
- With a purity exceeding 98%, this intermediate guarantees reliable results in complex chemical synthesis, supporting efficient API development.
Key Advantages
High Purity for Reliable Synthesis
Achieve consistent and dependable results in your pharmaceutical synthesis processes, thanks to the guaranteed >98% purity of this essential compound.
Critical for Cardiovascular Drugs
This intermediate is a cornerstone in the production of advanced medications like Edoxaban, directly impacting treatments for cardiovascular diseases.
Enabling FXa Inhibitor Development
Facilitate the creation of potent FXa inhibitors, essential for novel antithrombotic therapies, by utilizing this key chemical precursor.
Key Applications
Pharmaceutical Synthesis
Used as a critical reagent in the multi-step synthesis of Active Pharmaceutical Ingredients (APIs), contributing to the development of new medicines.
Antithrombotic Drug Development
Essential for building the molecular structure of antithrombotic agents, vital for preventing and treating conditions like deep vein thrombosis and pulmonary embolism.
FXa Inhibitor Synthesis
Serves as a key precursor in the creation of Factor Xa (FXa) inhibitors, a class of direct oral anticoagulants (DOACs).
Edoxaban Manufacturing
This compound is a direct intermediate in the manufacturing process of Edoxaban, an important anticoagulant medication.